Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
42,194,093
-
Total 13F shares
-
12,759,585
-
Share change
-
+12,759,585
-
Total reported value
-
$523,637,183
-
Price per share
-
$41.33
-
Number of holders
-
39
-
Value change
-
+$523,637,191
-
Number of buys
-
39
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) as of Q4 2020
As of 31 Dec 2020,
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,759,585 shares.
The largest 10 holders included
Vivo Capital, LLC, RTW INVESTMENTS, LP, FRAZIER MANAGEMENT LLC, Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, SANDS CAPITAL MANAGEMENT, LLC, and Ensign Peak Advisors, Inc.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.